Janus Henderson Group PLC Haemonetics Corp Transaction History

Janus Henderson Group PLC

$178 Billion
Q1 2024

A detailed history of Janus Henderson Group PLC transactions in Haemonetics Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 29,730 shares of HAE stock, worth $2.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,730

Previous 23,443 26.82%

Holding current value

$2.46 Million

Previous $2 Million 26.6%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$71.24 - $85.35 $447,885 - $536,595	6,287 Added 26.82%	29,730 $2.54 Million
Q4 2023 Feb 14, 2024	BUY	$80.59 - $92.61 $55,445 - $63,715	688 Added 3.02%	23,443 $2 Million
Q3 2023 Nov 14, 2023	BUY	$82.56 - $93.49 $330 - $373	4 Added 0.02%	22,755 $2.04 Million
Q2 2023 Aug 14, 2023	SELL	$80.84 - $89.45 $2,344 - $2,594	-29 Reduced 0.13%	22,751 $1.94 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $893,879 - $1.11 Million	12,287 Added 117.1%	22,780 $1.89 Million

Q4 2022 Feb 14, 2023	BUY	$73.85 - $86.14 $774,908 - $903,867	10,493 New	10,493 $825,000
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $87,227 - $108,393	-1,378 Reduced 13.38%	8,924 $661,000
Q2 2022 Aug 15, 2022	SELL	$49.27 - $66.08 $886 - $1,189	-18 Reduced 0.17%	10,302 $671,000
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $19 Million - $27.4 Million	-433,545 Reduced 97.67%	10,320 $652,000
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $37.7 Million - $56.7 Million	-760,819 Reduced 63.16%	443,865 $23.5 Million
Q3 2021 Nov 16, 2021	BUY	$57.6 - $70.59 $29.5 Million - $36.2 Million	512,612 Added 74.07%	1,204,684 $85 Million
Q2 2021 Aug 16, 2021	BUY	$51.81 - $118.56 $35.9 Million - $82.1 Million	692,072 New	692,072 $46.1 Million

Others Institutions Holding HAE

# of Institutions

310

Shares Held

50.1M

Call Options Held

161K

Put Options Held

56.3K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.25B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Haemonetics Corp Transaction History